Introduction {#Sec1}
============

Orthognathic surgery is a common surgery with its own specific set of complications^[@CR1],[@CR2]^. Surgical site infections (SSI) following orthognathic surgery occurs in 1.4 to 33.4% of cases. They are a major concern for surgical teams^[@CR3],[@CR4]^. Preventive and therapeutic management is not standardized. The indication for antibiotic therapy or antibiotic prophylaxis in orthognathic surgery is still debated^[@CR5]^. Practices vary widely amongst different teams with respect to the choice of antibiotic type and duration of treatment^[@CR6],[@CR7]^. However commonly accepted good practice parameters mandate that antibiotic use should be kept to the minimum necessary to prevent bacterial resistance. Furthermore, there is no data in the literature regarding the severity and long-term complications of SSI in orthognathic surgery. Specifically, the rates of extensive cellulitis, osteomyelitis, pseudarthrosis and interruptive mandibulectomy remain unknown^[@CR8]^. Our hypothesis was that single dose antibioprophylaxis was not associated with a high rate of severe postoperative complications. The purpose of this descriptive study was to measure the initial severity and the long-term consequences of postoperative infections following orthognathic surgery.

Methods {#Sec2}
=======

We performed a retrospective screening of all the patients operated on for orthognathic surgery between January 2015 and June 2017 in our department of maxillofacial surgery. Our hypothesis was that the rate of severe postoperative infections was low. All patients with SSI were included. Orthognathic surgery was defined as any of the following procedures: bilateral sagittal split osteotomy (BSSO), Le Fort 1 osteotomy, bimaxillary osteotomy, intermaxillary disjunction, and genioplasty. Third molar extractions could be associated to any of these procedures. Infection was defined by any persistent inflammatory reaction after orthognathic surgery, such as swelling, pus or development of cellulitis. Episodes of infections following hardware removal were not included^[@CR5],[@CR9],[@CR10]^. All patients were followed up for at least 6 months. Informed consent was obtained from all participants. This research was approved by the local ethics committee (Collège régional de Chirurgie Maxillo-Faciale) on May 2, 2019, and was performed in accordance with the guidelines reported in the ethical principles for medical research involving human subjects (World Medical Association Declaration of Helsinki).

Surgical procedure {#Sec3}
------------------

All patients were asked to stop smoking at least 10 days before surgery. They were operated on by senior surgeons, under general anesthesia and induced hypotension. The surgical site was prepared with povidone-iodine solution before surgery---including intra oral teeth and tongue brushing with the same solution. Standard peroperative IV prophylatic antibiotic were given to all patients, based on SFAR (Société Française d'Anesthésie Réanimation, *French Society of Anesthesia*) recommendations: intravenous AMOXICILLIN CLAVULANIC ACID 2 g was given during anesthesia induction, followed by 1 g every 2 h of operative time; in patients allergic to penicillin, intravenous CLINDAMYCIN 900 mg was given, followed by 600 mg every 4 h of operative time^[@CR11]^.

Le Fort osteotomy was performed using a reciprocating saw or Piezotome. The maxilla was segmented if needed. Fixation of the maxilla and BSSO was obtained using titanium mini plates. Third molars were removed at the time of surgery if necessary. Surgical wounds were sutured with Ethicon coated VICRYL 3.0 sutures (Johnson and Johnson International).

Patients were kept in hospital for at least 2 nights after the surgery. A course of antibiotics was not routinely prescribed postoperatively. Radiographic control was performed on post-op day 1. All patients had postoperative intermaxillary elastic banding for 1 month. The patients were discharged on postoperative day 2 with a soft diet, analgesics, teethbrushing after each meal and 0.12% CHLOREXIDINE mouthwashes^[@CR12]^. Standard post-operative care and oral hygiene instructions were given to each patients. They were seen in consultation at 2 weeks, 1 month, 3 months and 6 months postoperatively.

When SSI occured, antibiotics were prescribed for 10 to 15 days and oral hygiene was re-emphasized. The first line antibiotic was AMOXICILLIN CLAVULANIC ACID 1 g every 8 h. CLINDAMYCIN 600 mg every 8 h was the second line treatment in case of penicllin allergy. When the clinical and radiological evaluation demonstrated a collection, a surgical drainage was performed: local collection were drained under local anesthesia and irrigated with a normal saline solution. Extensive collections were drained under general anesthesia.

In case of osteomyelitis (Fig. [1](#Fig1){ref-type="fig"}), the patient was managed in collaboration with the infectious diseases department. Following surgical cleansing and bacteriological sampling, culture directed antibiotics were selected and administered for a period of 6 weeks to 3 months.Figure 1Axial view of Cone Beam CT: right mandibular osteomyelitis.

Study variables {#Sec4}
---------------

The following variables were collected: medical history (including tobacco use, diabetes, immunosuppressive treatment or pathology) age, sex, body mass index (BMI), type of surgery, time between surgery and infection, infection severity and local evolution.

Data collection {#Sec5}
---------------

Every complication occuring in the 6 months following surgery was documented. Antibiotic type, duration of treatment, surgical drainage and patient's evolution were recorded.

The initial SSI severity was defined by the following presentations: cellulitic reaction treated with oral antibiotics, local collection requiring surgical drainage under local anaesthesia, and extensive cellulitis needing surgical drainage under general anesthesia.

The evolution of SSI was classified according to the following categories: complete recovery, plate loosening or pain requiring hardware removal, and long-term complications (osteomyelitis or pseudarthrosis). The diagnosis of osteomyelitis was based on clinical history, sampling of the bone and histopathological characteristics^[@CR13]^.

Statistical analysis {#Sec6}
--------------------

Categorical variables were described with frequencies and proportions, quantitative variables were described with median and interquartile range. The analysis was carried out using R Software version 3.5.0^[@CR14]^.

Results {#Sec7}
=======

Patients demographic characteristics {#Sec8}
------------------------------------

A total of 512 patients underwent orthognathic surgery between January 2015 and July 2017. The characteristics of the patients presenting with SSI are given in Table [1](#Tab1){ref-type="table"}. A total of 41 patients (8%) were diagnosed with post-operative infection (Fig. [2](#Fig2){ref-type="fig"}). The age at the time of surgery ranged from 15 to 51 years old (median 20, mean 23.6). Nineteen patients had BSSO (46.3%), 21 had a bimaxillary surgery (51.2%), and one had isolated Le Fort 1 osteotomy (2.4%). The infection site was mandibular in 38 patients and maxillary in 3 patients. No infection was observed in genioplasty. Twenty-six patients were smokers (56%). The infection occurred on average 31.5 days and median 25 days after the surgery. No adverse effects of the antibiotics were reported.Table 1Demographic characteristics of patients presenting with SSI.OutcomeUncomplicated recoveryHardware removalLong-term complicationTotalN = 34N = 5N = 2N = 41**Sex**F20 (58.8%)3 (60.0%)1 (50.0%)24 (58.5%)H14 (41.2%)2 (40.0%)1 (50.0%)17 (41.5%)**Age**Mean (SD)23.41 (8.49)19.60 (3.78)37.50 (3.54)23.6 (8.5)Median (IQR)19.5 (17--29)18 (17--20)37.5 (35--40)20 (17--29)Allergy to penicillinYES3003 (7.3%)NO315238 (92.7%)**Genioplasty**YES5 (14.7%)0 (0.0%)0 (0.0%)5 (12.2%)NO29 (85.3%)5 (100.0%)2 (100.0%)36 (87.8%)**Wisdom teeth**YES8 (23.5%)2 (40.0%)0 (0.0%)10 (24.4%)NO26 (76.5%)3 (60.0%)2 (100.0%)31 (75.6%)**Smoker**NO23 (67.6%)3 (60.0%)0 (0.0%)26 (63.4%)YES11 (32.4%)2 (40.0%)2 (100.0%)15 (36.6%)DIABETESNO345241 (100%)YES0000**Immunosuppression**NO345140 (97.6%)YES0011 (2.4%)**BMI (kg/m**^**2**^**)**Mean20.62224.921.04N \< 2528 (82.3%)4 (80%)1 (50%)33 (80.5%)N = 25--306 (17.7%)1 (20%)1 (50%)8 (19.5%)N \> 300000**Time interval from surgery to infection**Mean (SD)31.32 (23.95)26.40 (27.21)47.50 (24.75)31.5 (24.0)Median (IQR)25.5 (11--48)24 (6--25)47.5 (30--65)25 (11--48)SurgeryBimaxillary19 (55.9%)2 (40.0%)0 (0.0%)21 (51.2%)BSSO14 (41.2%)3 (60.0%)2 (100.0%)19 (46.3%)Le Fort 11 (2.9%)0 (0.0%)0 (0.0%)1 (2.4%)**Infection location**Mandible31 (91.2%)5 (100.0%)2 (100.0%)38 (92.7%)Maxillary3 (8.8%)0 (0.0%)0 (0.0%)3 (7.3%)**Initial severity of infection**Cellulitic reaction20 (58.8%)2 (40.0%)2 (100.0%)24 (58.5%)Local collection12 (35.3%)3 (60.0%)0 (0.0%)15 (36.6%)Extensive cellulitis2 (5.9%)0 (0.0%)0(0.0%)2 (4.9%) Figure 2Schematic repartition ofsource population.

Infection severity {#Sec9}
------------------

Twenty-four patients were treated only with antibiotics and mouthwashes for a cellulitic reaction (58.5%), 15 patients needed both oral antibiotics as well as an incision and drainage under local anesthesia (36.6%), and 2 patients required surgical drainage under general anesthesia for extensive cellulitis (4.9%)(Fig. [3](#Fig3){ref-type="fig"}). No patient required intensive care unit admission. Bacteriologic cultures and sensitivity testing on samples were only conducted for patients requiring drainage under general anesthesia.Figure 3Initial severity of infections.

Local evolution {#Sec10}
---------------

Thirty-four patients had a quick and complete recovery (82.9%). Five patients needed hardware removal for loose screws (12.2%). Two cases developed chronic osteomyelitis (4.9%) (Figs. [1](#Fig1){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). No case of pseudarthrosis was observed (Table [1](#Tab1){ref-type="table"}).Figure 4Local evolution after infection.

The two patients who developed osteomyelitis were initially treated with a single antibiotic for a local cellulitic reaction. All patients who needed general anesthesia for extensive drainage had a complete and quick recovery (Figs. [5](#Fig5){ref-type="fig"} and [6](#Fig6){ref-type="fig"}). Patients treated with CLINDAMYCIN all had a complete and quick recovery.Figure 5Local evolution according to initial presentation. Figure 6Extensive cellulitis with purulent collection after bilateral sagittal split osteotomy (CT scan, axial and coronal views).

One of the two patients presenting with osteomyelitis was treated for rheumatoid arthritis with METHOTREXATE and ADALILUMAB. These treatments were discontinued 2 months before surgery (Fig. [1](#Fig1){ref-type="fig"}). The 2 cases of osteomyelitis resolved under medical treatment without requiring interruptive mandibulectomy.

Discussion {#Sec11}
==========

According to this study, the overall rate of severe SSI is acceptable. These results are consistent with other published series in which a single prophylactic dose of AMOXICILLIN CLAVULANIC ACID was used^[@CR3],[@CR15],[@CR16]^. Indeed, Chow et al. published the largest series in the literature on that topic and reported a rate of SSI of 7.4%, with a higher prevalence for mandibular location, compared with maxillary site^[@CR17]--[@CR19]^.

Orthognathic surgery is a clean contaminated surgery and is therefore expected to have a higher rate of SSI than non-contaminated surgery. As proven by Zijderveld et al., preoperative prophylaxis is known to decrease postoperative infections in orthognathic surgery^[@CR20]^. Yet, there is significant heterogeneity regarding the choice of preoperative antibiotic in literature (Table [2](#Tab2){ref-type="table"}). Barrier et al.noticed a higher rate of SSI when an antibiotic other than AMOXICILLIN CLAVULANIC ACID was used as prophylaxis^[@CR3]^. There is evidence suggesting that AMOXICILLIN CLAVULANIC ACID is the best molecule for single dose pre-operative antibioprophylaxis^[@CR6],[@CR7],[@CR21]--[@CR24]^. These principles are in concordance with the French recommendations for antibiotic prophylaxis from the French Society of Anesthesia and Intensive Care Medicine (SFAR) which were respected in this study^[@CR11]^.Table 2Reported strategies of antibiotics in the perioperative period.StudyStudy groupsPre- and peri-operative antibioticPost-operative antibioticInfection rate*p*Lindeboom et al. (2003)^[@CR29]^1 dose regimen4 doses regimenClindamycin 600 mg intravenously (IV), 15 min preoperativelyClindamycin 600 mg intravenously, 15 min preoperativelySaline solution intravenously, every 6 h for 24 hClindamycin 600 mg intravenously, every 6 h for 24 h5.71% (2/35)2.9% (1/35)*p* \> 0.05Barrier et al. (2009)^[@CR3]^1 dose groupAmoxicillin 1 g intravenously 30 mn preoperatively and every 2 h perioperativelynone7.0% (10/143)Chow et al. (2007)^[@CR17]^Penicillin and non penicillin antibiotics prophylaxisnone7.4% (96/1,294)Ghantous et al. (2019)^[@CR28]^Intervention groupAmoxi-clav 1 g perioperatively0.09% NaCl, 50 mL, every 8 h for 5 daysAmoxi-clav 1 g, every 8 h for 5 days2.5% (1/40)0% (0/38)*p* = 0.10Tan et al. (2011)^[@CR23]^Oral groupIntraveinous groupAmpicillin 1 g intravenously, and 500 mg every 6 hAmoxicillin 500 mg every 8 h + NaCl every 6 h during 2 days. Then amoxicillin 500 mg every 8 h during 3 daysAmpicillin 1 g every 6 h + oral lactose every 8 h during 2 days. Then amoxicillin 500 mg every 8 h during 3 days14.1% (3/21)28.6% (6/21)*p* = 0.45Zijderveld et al. (1999)^[@CR20]^Intervention groupComparison groupAmoxicillin clavulanate 2200 mg intravenously (30 mn preoperatively) OR cefuroxime 1,500 mg i.v. (30 min preoperatively)0.9% sodium chloride i.v. (30 min preoperatively)11--18%53%*p* \< 0.004Ruggles et al. (1984)^[@CR33]^Short term antibiotherapyLong-term antibiotherapyProcaine penicillin 600.00 U and penicillinG 400,000 U intravenously 1 hpreoperatively; penicillin G 2 g every30 min perioperativelyPenicillin G 2 g 3 hPostoperativelyPenicillin G 2 g every6 h for 5 days15% (3/20)0% (0/20)Baqain et al. (2004)^[@CR34]^Short-term antibiotherapyLong-term antibiotherapyAmoxicillin 1 mg intravenously atinduction or Clindamycin 300 mgintravenously at inductionAmoxicillin 500 mg orclindamycin 150 mg3 h postoperativelyAmoxicillin 500 mgevery 8 h orclindamycin 150 mgevery 6 h for 5 days23.5% (4/17)11.7% (2/17)*p* \> 0.05

The treatment duration has been debated. Several authors showed that infection rates were lower with systematic extended postoperative antibiotics^[@CR4],[@CR16],[@CR22],[@CR25]--[@CR27]^. Nevertheless, these findings were recently challenged by Ghantous et al.in a prospective randomized double blind placebo controlled clinical trial^[@CR28]^. Lindeboom et al.reported similar findings in a prospective randomized trial evaluating the SSI rates with CLINDAMYCIN (Table [2](#Tab2){ref-type="table"})^[@CR29],[@CR30]^.

Excessive use of antibiotics carries its own sets of complications^[@CR31]^. A postoperative antibiotic course is not recommended after surgery in international literature^[@CR6],[@CR11]^. Short-term prophylaxis reduces adverse effects, decreases selection of resistant bacterial strains, and is more cost effective. Thus, systematic antibiotic treatment cannot be recommended given the available evidence.

Overall, the low rate of local complications as well as the plethora of possible adverse effects from extended antibiotic therapy support the indication for single dose preoperative antibioprophylaxis.

Of note, the delay between the surgery and the development of an infection could be surprising with an average of 31.51 days. This delay is however consistent with other published data. For instance, in the study of Chow et al., the delay between surgery and infection ranged from 3 to 4 weeks postoperatively^[@CR17]^. The delay found in the current study might be overestimated. Indeed, the date of infection was noted as the date at which the patient presented out medical attention on our service.

It must be highlighted that the two patients presenting with osteomyelitis were smokers and showed a higher mean delay between surgery and infection (47.5 days vs 30 days; Table [1](#Tab1){ref-type="table"}). The relationship between active tobacco use and the increased risk of infectious complications is well established in the orthopedic surgery literature^[@CR32]^. Furthermore, the patients treated for long-term complications in our series were older with an average age of 37.5 years as opposed to 19.6 years for patients needing only hardware removal and 23.4 years for those recovering promptly following oral antibiotics only in the rest of the series. Moreover, one patient was immunosuppressed, which is a major risk factor of infection.

These results suggest that smokers, immunosuppressed patients and patients over 35 years old should be followed more closely in the postoperative period, looking for osteomyelitis (Fig. [7](#Fig7){ref-type="fig"}). A larger comparative series would be useful to specifically determine the risk factors of severe SSI. The indication for systematic extended postoperative antibiotic therapy for identified high-risk patients could be discussed.Figure 7Radiographic evolution of osteomyelitis: diagnosis (**A**), 1 day after hardware removal and surgical curettage (**B**), and 1 year after the antibiotic treatment (**C**).
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